Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

MedStar author(s):
Citation: New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.PMID: 30145941Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Anti-Obesity Agents/tu [Therapeutic Use] | *Benzazepines/tu [Therapeutic Use] | *Cardiovascular Diseases/co [Complications] | *Hypoglycemia/ci [Chemically Induced] | *Obesity/dt [Drug Therapy] | *Overweight/dt [Drug Therapy] | *Weight Loss/de [Drug Effects] | Aged | Anti-Obesity Agents/ae [Adverse Effects] | Aortic Valve Insufficiency/ci [Chemically Induced] | Benzazepines/ae [Adverse Effects] | Cardiovascular Diseases/ci [Chemically Induced] | Cardiovascular Diseases/ep [Epidemiology] | Diabetes Mellitus, Type 2/co [Complications] | Double-Blind Method | Female | Follow-Up Studies | Humans | Hypertension, Pulmonary/ci [Chemically Induced] | Male | Middle Aged | Obesity/co [Complications] | Overweight/co [Complications] | Risk FactorsYear: 2018ISSN:
  • 0028-4793
All authors: Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SDOriginally published: New England Journal of Medicine. 2018 Aug 26Fiscal year: FY2019Digital Object Identifier: Date added to catalog: 2018-08-31
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30145941 Available 30145941


Powered by Koha